ALGS
Price
$9.87
Change
+$0.66 (+7.17%)
Updated
Dec 3 closing price
Capitalization
60.74M
Intraday BUY SELL Signals
DMAC
Price
$8.51
Change
+$0.53 (+6.64%)
Updated
Dec 3 closing price
Capitalization
443.18M
117 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGS vs DMAC

Header iconALGS vs DMAC Comparison
Open Charts ALGS vs DMACBanner chart's image
Aligos Therapeutics
Price$9.87
Change+$0.66 (+7.17%)
Volume$52.71K
Capitalization60.74M
DiaMedica Therapeutics
Price$8.51
Change+$0.53 (+6.64%)
Volume$337.84K
Capitalization443.18M
ALGS vs DMAC Comparison Chart in %
ALGS
Daily Signal:
Gain/Loss:
DMAC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALGS vs. DMAC commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and DMAC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ALGS: $9.31 vs. DMAC: $7.99)
Brand notoriety: ALGS and DMAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 69% vs. DMAC: 63%
Market capitalization -- ALGS: $60.74M vs. DMAC: $443.18M
ALGS [@Biotechnology] is valued at $60.74M. DMAC’s [@Biotechnology] market capitalization is $443.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileDMAC’s FA Score has 0 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • DMAC’s FA Score: 0 green, 5 red.
According to our system of comparison, ALGS is a better buy in the long-term than DMAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 5 TA indicator(s) are bullish while DMAC’s TA Score has 5 bullish TA indicator(s).

  • ALGS’s TA Score: 5 bullish, 5 bearish.
  • DMAC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ALGS and DMAC are a good buy in the short-term.

Price Growth

ALGS (@Biotechnology) experienced а -3.62% price change this week, while DMAC (@Biotechnology) price change was -11.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

DMAC is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DMAC($443M) has a higher market cap than ALGS($60.7M). DMAC YTD gains are higher at: 47.145 vs. ALGS (-76.632). DMAC has higher annual earnings (EBITDA): -31.42M vs. ALGS (-75.81M). ALGS has more cash in the bank: 123M vs. DMAC (30M). DMAC has less debt than ALGS: DMAC (292K) vs ALGS (6.88M). ALGS has higher revenues than DMAC: ALGS (3.17M) vs DMAC (0).
ALGSDMACALGS / DMAC
Capitalization60.7M443M14%
EBITDA-75.81M-31.42M241%
Gain YTD-76.63247.145-163%
P/E RatioN/AN/A-
Revenue3.17M0-
Total Cash123M30M410%
Total Debt6.88M292K2,355%
FUNDAMENTALS RATINGS
DMAC: Fundamental Ratings
DMAC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALGSDMAC
RSI
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
Momentum
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
81%
MACD
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 22 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signal:
Gain/Loss:
DMAC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOCQX55.30N/A
N/A
Tocqueville
FZALX30.57N/A
N/A
Fidelity Advisor Mega Cap Stock Z
SLGAX16.74N/A
N/A
SEI Large Cap F (SIMT)
FWOMX19.35N/A
N/A
Fidelity Women's Leadership
LTAGX16.93N/A
N/A
Lord Abbett International Growth R5

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with BEAM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+0.11%
BEAM - ALGS
45%
Loosely correlated
-2.83%
SYRE - ALGS
45%
Loosely correlated
-0.91%
ARWR - ALGS
44%
Loosely correlated
+3.08%
XNCR - ALGS
44%
Loosely correlated
-3.15%
RXRX - ALGS
42%
Loosely correlated
-0.69%
More

DMAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMAC has been loosely correlated with WHWK. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if DMAC jumps, then WHWK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMAC
1D Price
Change %
DMAC100%
-2.44%
WHWK - DMAC
41%
Loosely correlated
-2.88%
IPSC - DMAC
38%
Loosely correlated
-2.62%
CDXS - DMAC
36%
Loosely correlated
-0.30%
LQDA - DMAC
34%
Loosely correlated
-3.96%
ALGS - DMAC
34%
Loosely correlated
+0.11%
More